NewAmsterdam Pharma (NAMS) Leases (2022 - 2025)
Historic Leases for NewAmsterdam Pharma (NAMS) over the last 4 years, with Q3 2025 value amounting to $246000.0.
- NewAmsterdam Pharma's Leases fell 5010.14% to $246000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $246000.0, marking a year-over-year decrease of 5010.14%. This contributed to the annual value of $431000.0 for FY2024, which is 68363.64% up from last year.
- Latest data reveals that NewAmsterdam Pharma reported Leases of $246000.0 as of Q3 2025, which was down 5010.14% from $308000.0 recorded in Q2 2025.
- NewAmsterdam Pharma's 5-year Leases high stood at $554000.0 for Q2 2024, and its period low was $38000.0 during Q1 2024.
- For the 4-year period, NewAmsterdam Pharma's Leases averaged around $290444.4, with its median value being $308000.0 (2025).
- Per our database at Business Quant, NewAmsterdam Pharma's Leases plummeted by 5416.67% in 2023 and then soared by 87105.26% in 2025.
- NewAmsterdam Pharma's Leases (Quarter) stood at $120000.0 in 2022, then tumbled by 54.17% to $55000.0 in 2023, then surged by 683.64% to $431000.0 in 2024, then plummeted by 42.92% to $246000.0 in 2025.
- Its Leases stands at $246000.0 for Q3 2025, versus $308000.0 for Q2 2025 and $369000.0 for Q1 2025.